立体定向体部放疗的采用影响前列腺癌治疗模式
研究利用SEER-Medicare数据识别2008至2017年局限性前列腺癌患者,按治疗医生归属划分医生网络,比较开展与未开展立体定向体部放疗(SBRT)网络的治疗趋势。结果显示SBRT使用相对其他治疗增加,开展SBRT的网络治疗构成不同,黑人男性接受SBRT的可能性比白人男性低45%(OR=0.55,CI:0.36-0.85)。
要点
- 开展SBRT的医生网络中,接受IMRT者更多(31% vs 23%),接受前列腺切除术者更少(16% vs 23%),接受主动监测者更少(15% vs 19%)。
- 黑人男性接受SBRT的可能性比白人男性低45%(OR=0.55,CI:0.36-0.85)。
- SBRT使用相对其他前列腺癌治疗呈增加趋势,部分患者群体SBRT可及性较低。
核心结论
- SBRT使用相对其他前列腺癌治疗呈增加趋势。
- 开展SBRT的网络前列腺癌治疗构成不同,且SBRT对部分患者群体可及性较低,引发对新型治疗不公平的担忧。
研究设计与样本
- 利用SEER-Medicare识别2008至2017年诊断为局限性前列腺癌的患者。
- 根据主要治疗确定每位患者的主治医生,再将医生链接至执业机构以识别医生网络。
- 共纳入35972例接受前列腺癌治疗的患者,分布于234个医生网络。
- 其中30635例在未开展SBRT的网络(n=190)接受治疗,5337例在开展SBRT的网络(n=44)接受治疗。
- 使用卡方检验和逻辑回归模型分析开展与未开展SBRT网络间的治疗趋势。
主要发现
- 开展SBRT网络的患者更可能收入中位数>$60,000(62% vs 42%,P<.001)。
- 开展SBRT网络的患者更可能居住在东北部(35% vs 12%)或西部(40% vs 38%,P<.001)。
- 开展SBRT网络中更多患者接受IMRT(31% vs 23%),更少患者接受前列腺切除术(16% vs 23%)或主动监测(15% vs 19%)。
- 黑人男性接受SBRT的可能性比白人男性低45%(OR=0.55,CI:0.36-0.85)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate stereotactic body radiation (SBRT) adoption for prostate cancer. As evidence supporting SBRT mounts, its utilization and impact relative to other prostate cancer treatments is unknown. METHODS: We used SEER-Medicare to identify patients diagnosed with localized prostate cancer from 2008 to 2017. We then identified physician networks by identifying the primary treating physician of each patient based on primary treatment, then linking each physician to a practice. We examined trends in prostate cancer treatment between networks performing SBRT or not using chi-squared tests and logistic regression models. RESULTS: There were 35,972 patients who received treatment for prostate cancer at 234 physician networks. Of these patients, 30,635 were treated in a non-SBRT network (n = 190), while 5337 received treatment in a SBRT network (n = 44). Patients who received care in an SBRT network were more likely to live in metropolitan areas ≥1 million (70% vs 46%, P <.001), have a higher median income >$60,000 (62% vs 42%, P <.001), and live in the northeast (35% vs 12%) or west (40% vs 38%, P <.001) compared to non-SBRT networks. In SBRT networks, more patients received IMRT (31% vs 23%), and fewer patients received prostatectomy (16% vs 23%) or active surveillance (15% vs 19%) compared to non-SBRT networks. Black men were 45% less likely to receive SBRT (OR=0.55, CI: 0.36-0.85) compared to White men. CONCLUSION: SBRT utilization is increasing relative to other prostate cancer treatments. Prostate cancer treatment mix is different in networks that offer SBRT, and SBRT is less available to some patient groups, raising concern for novel treatment inequity.
引用
- Stencel MG, Wu S, Danielle SR, et al. Stereotactic Body Radiation Adoption Impacts Prostate Cancer Treatment Patterns. Urology. 2024. PMID: 39128635. doi:10.1016/j.urology.2024.07.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。